Chronic viral hepatitis C: management update - Wikidata - awgldk - TriplyDB

Chronic viral hepatitis C: management update

Chronic viral hepatitis C: management update

http://www.wikidata.org/entity/Q27471844

about

Hepatitis C: a review for primary care physicians Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C Synergistic In Vitro Interactions between Alpha Interferon and Ribavirin against Bovine Viral Diarrhea Virus and Yellow Fever Virus as Surrogate Models of Hepatitis C Virus Replication Strategic Approach To Produce Low-Cost, Efficient, and Stable Competitive Internal Controls for Detection of RNA Viruses by Use of Reverse Transcription-PCR Early treatment of acute hepatitis C infection may lead to cure Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.Treatment outcomes in a centralized specialty clinic for hepatitis C virus are comparable with those from clinical trials

P2860

Q22306040-0305AEA8-8409-4E58-834E-821DCBD1D7C6 Q26741123-878A1C7E-9E9B-429A-9C1D-B87E7BFE7D2D Q27477551-45975A28-6471-4D74-A383-DA5C41F80E51 Q27484878-F78B8A88-580F-413F-8DFD-7BE042D7E01F Q28344206-8C202468-BB0A-4434-9EBB-9323FE028BF4 Q33428399-03741496-AE3E-4101-986B-F786E517502A Q36272393-7B81FF50-DA69-41C5-9EE1-F5920C317B12 Q36398141-EEC26A88-DEE2-4F6F-B971-13ACA3D8D6FC

P2860

Chronic viral hepatitis C: management update

http://www.wikidata.org/entity/Q27471844

description

2000 nî lūn-bûn

@nan

2000 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մարտին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Chronic viral hepatitis C: management update

@ast

Chronic viral hepatitis C: management update

@en

Chronic viral hepatitis C: management update

@nl

type

label

Chronic viral hepatitis C: management update

@ast

Chronic viral hepatitis C: management update

@en

Chronic viral hepatitis C: management update

@nl

prefLabel

Chronic viral hepatitis C: management update

@ast

Chronic viral hepatitis C: management update

@en

Chronic viral hepatitis C: management update

@nl

P1433

Q27471844-7AD32347-E2B6-4DEE-A0E7-C166DEF26F25

P1476

Q27471844-B477B3A0-0844-4111-B224-F73E898DA8FB

P2093

Q27471844-2CA664CA-11B1-499A-BB68-1010120A8D7F

Q27471844-47E2DACA-9BE1-4F85-AC4E-9EEAA580C127

P2860

Q27471844-0FD07435-4839-475A-8A15-E9DCA0BB87C0

Q27471844-16734552-4537-4099-AB46-69F4EECD79F0

Q27471844-17E41A7A-38C6-4791-A180-D05A30AF0CB0

Q27471844-24223A1E-79C6-47A5-943E-66BF4EB15A7E

Q27471844-29767CDD-BC2D-43AB-A01C-68848375CE6B

Q27471844-2B49B9D1-FD79-4BDC-94BD-8BF4ECDFA8D2

Q27471844-2CB56D57-B7FF-492B-A532-D9506ECB6CBE

Q27471844-3235A0EE-6E07-46CE-84DC-8EBD36AD6A59

Q27471844-3D6179D4-6481-4C1C-8D73-9ED9192AC830

Q27471844-407B94D0-4B06-4C22-B791-0CF3970FDD62

P304

Q27471844-D33F7D11-81B7-4956-81EC-616FB8035663

P31

Q27471844-66BA2228-3598-4A22-9428-D625DB3CE1F8

P3181

Q27471844-431F855F-F637-4340-9455-7F4436B5558C

P407

Q27471844-D2CD0F2B-3546-43FD-8100-8B6D6F169DF6

P433

Q27471844-18FF4F20-B939-4839-979B-1242FD33F900

P478

Q27471844-653A7E4C-E437-4CAF-8A8A-915540CBF3F8

P577

Q27471844-8E2E1EDF-39BF-4E66-9963-2C00D92E6C99

P698

Q27471844-BD75D0CF-EC39-40B5-8F90-12502C4B8E9C

P932

Q27471844-B575D7D8-BC9A-4C6E-82AB-ACEBA7C92E8E

P3181

P1433

Canadian Medical Association Journal

P1476

Chronic viral hepatitis C: management update

@en

P2093

K S Gutfreund

http://www.w3.org/2001/XMLSchema#string

V G Bain

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of bloodborne infective agents among people admitted to a Canadian hospital

Hepatitis C virus recurrence after liver transplantation

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Epidemiology of hepatitis C

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

Use of high-dose interferon in the treatment of chronic hepatitis C.

The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C.

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.

P304

827-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

777981

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P577

2000-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10750473

http://www.w3.org/2001/XMLSchema#string

P932

1231279

http://www.w3.org/2001/XMLSchema#string